SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor

Cuiling Zhang1, Qiwei Jiang1, Zirui Liu1

  • 1Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Journal of Virology
|October 24, 2024
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) NSP6 protein disrupts autophagy by inhibiting lysosome function. Sigma-1 receptor knockout reversed these effects and resisted SARS-CoV-2 infection, suggesting it as a therapeutic target.

Area of Science:

  • Virology
  • Cellular Biology
  • Immunology

Background:

  • Autophagy is a cellular process involved in pathogen defense and replication.
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structure protein 6 (NSP6) is implicated in modulating autophagy.
  • The precise mechanisms by which SARS-CoV-2 NSP6 affects autophagy and viral replication remain unclear.

Purpose of the Study:

  • To investigate the impact of SARS-CoV-2 NSP6 on autophagosome formation and function.
  • To elucidate the role of sigma-1 receptor (SIGMAR1) in SARS-CoV-2 infection and autophagy modulation.
  • To identify potential therapeutic targets for SARS-CoV-2 infection.

Main Methods:

  • Investigated the effect of NSP6 from wild-type and Delta SARS-CoV-2 variants on autophagosome size.
  • Examined the localization of SARS-CoV-2 NSP6 and its interaction with lysosomes.
  • Assessed the impact of SIGMAR1 knockout (KO) on SARS-CoV-2 infection and autophagy.
  • Analyzed endoplasmic reticulum (ER)-related pathways involved in NSP6-mediated autophagy inhibition.

Main Results:

  • SARS-CoV-2 NSP6 reduced autophagosome size in wild-type and Delta variants.
  • NSP6 localized to lysosomes, inhibiting autophagosome-lysosome fusion and blocking autophagy flux.
  • SIGMAR1 KO reversed NSP6-induced autophagosome abnormalities and conferred resistance to SARS-CoV-2 infection.
  • NSP6-induced autophagy inhibition may involve ER-related pathways.

Conclusions:

  • SARS-CoV-2 NSP6 impairs autophagy by disrupting autophagosome-lysosome fusion, potentially via ER-related mechanisms.
  • SIGMAR1 plays a critical role in SARS-CoV-2 pathogenesis and autophagy modulation.
  • SIGMAR1 represents a promising therapeutic target for developing novel anti-SARS-CoV-2 drugs.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.1K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Viruses of Archaea01:29

Viruses of Archaea

Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...